Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 11, 2009, Pages 1920-1928

  Cittadini, A ^a   Monti, M G ^a   Castiello, M C ^a   D'arco, E ^a   Galasso, G ^a   Sorriento, D ^a   Saldamarco, L ^a   De Paulis, A ^a   Napoli, R ^a   Iaccarino, G ^a   Sacca L ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Carotid arteries; Endothelium; IGF 1; Nitric oxide synthase; Restenosis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; PROTEIN KINASE B; SOMATOMEDIN C;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY MEDIA; ARTICLE; CAROTID ARTERY INJURY; CAROTID ARTERY OBSTRUCTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG POTENCY; ENDOTHELIUM CELL; HEART PROTECTION; HISTOPATHOLOGY; INTIMA; MITOSIS INHIBITION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REENDOTHELIALIZATION; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STEM CELL MOBILIZATION;

ANIMALS; BALLOON DILATATION; CAROTID ARTERY INJURIES; CAROTID STENOSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; INSULIN-LIKE GROWTH FACTOR I; PROTECTIVE AGENTS; RATS; REGENERATION; TUNICA INTIMA; TUNICA MEDIA;

EID: 70449413985     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03607.x     Document Type: Article

References (42)

1. Hayashi K, Shibata K, Morita T, Iwasaki K, Watanabe M, Sobue K. Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J Biol Chem 2004, 279:40807-18.
2. Bay HB, Pollman M, Inishi Y, Gibbons GH. Regulation of vascular smooth muscle cell apoptosis: modulation of Bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ Res 1999, 85:229-37.
3. Delafontaine P, Song Y-H, Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 2004, 24:435-44.
4. Michell BJ, Griffiths JE, Mitchelhill KI, Rodriguez-Crespo I, Tiganis T, Bozinovski S, Ortiz de Montellano PR, Kemp BE, Pearson RB. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol 1999, 9:845-8.
5. Isenovic ER, Divald A, Milivojevic N, Grgurevic T, Fisher SE, Sowers JR. Interactive effects of insulin-like Growth Factor-1 and β-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells. Metabolism 2003, 52:482-7.
6. Repetto S, Salani B, Maggi D, Cordera R. Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 mechanism. Biochem Biophys Res Commun 2005, 337:849-52.
7. Griendling KK, Fitzgerald GA. Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 2003, 108:2034-40.
8. Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994, 15:555-73.
9. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 1993, 129:195-200.
10. Lanes R, Soros A, Flores K, Gunczler P, Carrillo E, Bandel J. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters. J Clin Endocrinol Metab 2005, 90:3978-82.
11. Galasso G, Sciekofer S, Sato K, Shibata R, Handy DE, Ouchi N, Leopold JA, Loscalzo J, Walsh K. Imaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res 2006, 98:254-61.
12. Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD, Poole-Wilson PA, Borlak J, Ertl G, Bauersachs J. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 2007, 100:434-43.
13. Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res 1990, 66:1755-60.
14. Khorsandi MJ, Fagin JA, Giannella-Neto D, Forrester JS, Cercek B. Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity. J Clin Invest 1992, 90:1926-31.
15. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. Lab Invest 1983, 49:327-33.
16. Aloke V, Finnb Herman K, Tanga GB, Deena K, Webera TN, Wightc A, Clermontb R, Virmania F, Kolodgiea D. A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J Vasc Res 2002, 39:414-25.
17. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-24.
18. Tulis DA. Histological and morphometric analyses for rat carotid balloon injury model. Methods Mol Med 2007, 139:31-6.
19. Grant MB, Wargovich TJ, Bush D, Player DW, Caballero S, Foegh M, Spoerri PE. Expression of IGF-1, IGF-1 receptor and TGF-β following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: an immunocytochemical study. Regul Pept 1999, 79:47-53.
20. Zhu B, Zhao G, Witte DP, Hui DY, Fagin JA. Targeted overexpression of IGF-1 in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intrarterial injury. Endocrinology 2001, 142:3598-606.
21. Lim HJ, Park HY, Ko YG, Lee SH, Cho SY, Lee EJ, Jameson JL, Jang Y. Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation trough suppression of vascular smooth muscle cell migration and proliferation and induction of apoptosis. Biochem Biophys Res Commun 2004, 325:1106-14.
22. Santoian ED, Schneider J, Gravanis M, Foegh M, Tarazona N, Cipolla G, King SB. Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation 1993, 88:11-4.
23. Emanuelsson H, Beart KJ, Bagger JP, Balcon R, Heikkilä J, Piessens J, Schaeffer M, Suryapranata H, Foegh ML. Long-term effect of angiopeptin treatment in coronary angioplasty: reduction of clinical events but not angiographic restenosis. Circulation 1995, 91:1689-96.
24. Kursaklioglu SH, Iyisoy A, Amasyali B, Barcin C, Kose S, Celik T, Kilic A, Ozturk C, Demirtas E. Long-term effects of octreotide therapy on in-stent restenosis. Heart Vessels 2003, 18:130-5.
25. von Essen R, Ostermaier R, Grube E, Maurer W, Tebbe U, Erbel R, Roth M, Oel W, Brom J, Weidinger G. Effects of octreotide on restenosis after coronary angioplasty: results of the VERAS study. Circulation 1997, 96:1482-7.
26. Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di Rella F, Numis F, Merola B, Longobardi S, Saccà L. Abnormal vascular reactivity in growth hormone deficiency. Circulation 2001, 103:520-4.
27. Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S, Labrousse F, Pastene J, Sassolas A, Roux Y, Berthezene F. Decrease in carotid intima-media thickness in adults with GH deficiency. J Clin Endocrinol Metab 1999, 84:1329-33.
28. Capaldo B, Patti L, Oliviero U, Longobardi S, Pardo F, Vitale F, Fazio S, di Rella F, Biondi B, Lombardi G, Saccà L. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 1997, 82:1378-81.
29. DeBoer H, Blok GJ, van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995, 16:63-86.
30. Bengtsson BA, Gudmundur J. Effect of growth-hormone therapy on early atherosclerotic changes in GH-deficient adults. Lancet 1999, 353:1898-9.
31. Tsukahara RH, Gordienko DV, Tonshoff B, Gelato MC, Goligorscky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 1994, 45:598-604.
32. Veermeesch P, Nong Z, Stabile E, Varenne O, Gillijns H, Pellens M, van Pelt N, Hoylaerts M, De Scheerder I, Collen D, Janssens S. L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism. Arterioscler Thromb Vasc Biol 2001, 21:1604-9.
33. Janssens S, Flaherty D, Nong Z, Varenne O, van Pelt N, Haustermans C, Zoldhelyi P, Gerard R, Collen D. Human endothelial nitric oxide synthase gene transfer inhibits VSMC proliferation and neointima formation after balloon injury in rats. Circulation 1998, 97:1274-81.
34. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998, 101:731-6.
35. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, Huang PL. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 1998, 101:1225-32.
36. Holm AM, Anderson CB, Haunso S, Hansen PR. Effects of L-arginine on vascular smooth muscle cell proliferation and apoptosis after balloon-injury. Scand Cardiovasc J 2000, 34:28-32.
37. Sata M, Fukuda D, Tanaka K, Kaneda Y, Yashiro H, Shirakawa I. The role of circulating precursors in vascular repair and lesion formation. J Cell Mol Med 2005, 9:557-68.
38. Bär H, Wende P, Watson L, Denger S, van Eys G, Kreuzer J, Jahn L. Smoothelin is an indicator reversible phenotype of smooth muscle cells in balloon-injured rat carotid arteries. Basic Res Cardiol 2001, 97:9-16.
39. Zhou X, Beck C, Boren J, Akyurek LM. Diverse origin of vascular smooth cells in the neointima. Anadolu Kardiyol Derg 2005, 5:216-20.
40. Devin JK, Vaughan DE, Blevins LS, Chen Q, Covington J, Verity DK, Young PP. Low dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults. Growth Horm IGF Res 2008, 18:253-63.
41. Urao N, Inomata H, Razvi M, Kim HW, Wary K, McKinney R, Fukai T, Ushio-Fukai M. Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. Circ Res 2008, 103:212-20.
42. Thum T, Fleissner F, Klink I, Tsikas D, Jakob M, Bauersachs J, Stichtenoth DO. Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I. J Clin Endocrinol Metab 2007, 92:4172-9.